Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.
The global Recombinant Collagen-Based Biomaterial market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
Report Metric
Details
Report Title
Global Recombinant Collagen-Based Biomaterial Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Market Size Available for Years
2025-2031
Global Recombinant Collagen-Based Biomaterial Companies Covered
Evonik Industries
Trautec
Genemedicine
FibroGen
CollPlant
Geltor
Modern Meadow
Global Recombinant Collagen-Based Biomaterial Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Collagen-Based Biomaterial Market, Segment by Type
Medical Grade Recombinant Collagen
Cosmetic Grade Recombinant Collagen
Food Grade Recombinant Collagen
Others
Global Recombinant Collagen-Based Biomaterial Market, Segment by Application
Medical Industry
Cosmetic Industry
Food Industry
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Recombinant Collagen-Based Biomaterial market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cosmetic Grade Recombinant Collagen in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cosmetic Industry in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Collagen-Based Biomaterial value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Table of Contents
1 Market Overview
1.1 Recombinant Collagen-Based Biomaterial Product Scope
1.2 Recombinant Collagen-Based Biomaterial by Type
1.2.1 Global Recombinant Collagen-Based Biomaterial Sales by Type (2020 & 2024 & 2031)
1.2.2 Medical Grade Recombinant Collagen
1.2.3 Cosmetic Grade Recombinant Collagen
1.2.4 Food Grade Recombinant Collagen
1.2.5 Others
1.3 Recombinant Collagen-Based Biomaterial by Application
1.3.1 Global Recombinant Collagen-Based Biomaterial Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Medical Industry
1.3.3 Cosmetic Industry
1.3.4 Food Industry
1.3.5 Others
1.4 Global Recombinant Collagen-Based Biomaterial Market Estimates and Forecasts (2020-2031)
1.4.1 Global Recombinant Collagen-Based Biomaterial Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Recombinant Collagen-Based Biomaterial Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Recombinant Collagen-Based Biomaterial Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Recombinant Collagen-Based Biomaterial Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Recombinant Collagen-Based Biomaterial Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Recombinant Collagen-Based Biomaterial Sales Market Share by Region (2020-2025)
2.2.2 Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Region (2020-2025)
2.3 Global Recombinant Collagen-Based Biomaterial Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Recombinant Collagen-Based Biomaterial Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Recombinant Collagen-Based Biomaterial Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Recombinant Collagen-Based Biomaterial Market Size and Prospective (2020-2031)
2.4.2 Europe Recombinant Collagen-Based Biomaterial Market Size and Prospective (2020-2031)
2.4.3 China Recombinant Collagen-Based Biomaterial Market Size and Prospective (2020-2031)
2.4.4 Japan Recombinant Collagen-Based Biomaterial Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Recombinant Collagen-Based Biomaterial Historic Market Review by Type (2020-2025)
3.1.1 Global Recombinant Collagen-Based Biomaterial Sales by Type (2020-2025)
3.1.2 Global Recombinant Collagen-Based Biomaterial Revenue by Type (2020-2025)
3.1.3 Global Recombinant Collagen-Based Biomaterial Price by Type (2020-2025)
3.2 Global Recombinant Collagen-Based Biomaterial Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Recombinant Collagen-Based Biomaterial Sales Forecast by Type (2026-2031)
3.2.2 Global Recombinant Collagen-Based Biomaterial Revenue Forecast by Type (2026-2031)
3.2.3 Global Recombinant Collagen-Based Biomaterial Price Forecast by Type (2026-2031)
3.3 Different Types Recombinant Collagen-Based Biomaterial Representative Players
4 Global Market Size by Application
4.1 Global Recombinant Collagen-Based Biomaterial Historic Market Review by Application (2020-2025)
4.1.1 Global Recombinant Collagen-Based Biomaterial Sales by Application (2020-2025)
4.1.2 Global Recombinant Collagen-Based Biomaterial Revenue by Application (2020-2025)
4.1.3 Global Recombinant Collagen-Based Biomaterial Price by Application (2020-2025)
4.2 Global Recombinant Collagen-Based Biomaterial Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Recombinant Collagen-Based Biomaterial Sales Forecast by Application (2026-2031)
4.2.2 Global Recombinant Collagen-Based Biomaterial Revenue Forecast by Application (2026-2031)
4.2.3 Global Recombinant Collagen-Based Biomaterial Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Recombinant Collagen-Based Biomaterial Application
5 Competition Landscape by Players
5.1 Global Recombinant Collagen-Based Biomaterial Sales by Players (2020-2025)
5.2 Global Top Recombinant Collagen-Based Biomaterial Players by Revenue (2020-2025)
5.3 Global Recombinant Collagen-Based Biomaterial Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Collagen-Based Biomaterial as of 2024)
5.4 Global Recombinant Collagen-Based Biomaterial Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Product Type & Application
5.7 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Recombinant Collagen-Based Biomaterial Sales by Company
6.1.1.1 North America Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025)
6.1.1.2 North America Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025)
6.1.2 North America Recombinant Collagen-Based Biomaterial Sales Breakdown by Type (2020-2025)
6.1.3 North America Recombinant Collagen-Based Biomaterial Sales Breakdown by Application (2020-2025)
6.1.4 North America Recombinant Collagen-Based Biomaterial Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Recombinant Collagen-Based Biomaterial Sales by Company
6.2.1.1 Europe Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025)
6.2.1.2 Europe Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025)
6.2.2 Europe Recombinant Collagen-Based Biomaterial Sales Breakdown by Type (2020-2025)
6.2.3 Europe Recombinant Collagen-Based Biomaterial Sales Breakdown by Application (2020-2025)
6.2.4 Europe Recombinant Collagen-Based Biomaterial Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Recombinant Collagen-Based Biomaterial Sales by Company
6.3.1.1 China Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025)
6.3.1.2 China Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025)
6.3.2 China Recombinant Collagen-Based Biomaterial Sales Breakdown by Type (2020-2025)
6.3.3 China Recombinant Collagen-Based Biomaterial Sales Breakdown by Application (2020-2025)
6.3.4 China Recombinant Collagen-Based Biomaterial Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Recombinant Collagen-Based Biomaterial Sales by Company
6.4.1.1 Japan Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025)
6.4.1.2 Japan Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025)
6.4.2 Japan Recombinant Collagen-Based Biomaterial Sales Breakdown by Type (2020-2025)
6.4.3 Japan Recombinant Collagen-Based Biomaterial Sales Breakdown by Application (2020-2025)
6.4.4 Japan Recombinant Collagen-Based Biomaterial Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Evonik Industries
7.1.1 Evonik Industries Company Information
7.1.2 Evonik Industries Business Overview
7.1.3 Evonik Industries Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Evonik Industries Recombinant Collagen-Based Biomaterial Products Offered
7.1.5 Evonik Industries Recent Development
7.2 Trautec
7.2.1 Trautec Company Information
7.2.2 Trautec Business Overview
7.2.3 Trautec Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Trautec Recombinant Collagen-Based Biomaterial Products Offered
7.2.5 Trautec Recent Development
7.3 Genemedicine
7.3.1 Genemedicine Company Information
7.3.2 Genemedicine Business Overview
7.3.3 Genemedicine Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Genemedicine Recombinant Collagen-Based Biomaterial Products Offered
7.3.5 Genemedicine Recent Development
7.4 FibroGen
7.4.1 FibroGen Company Information
7.4.2 FibroGen Business Overview
7.4.3 FibroGen Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2020-2025)
7.4.4 FibroGen Recombinant Collagen-Based Biomaterial Products Offered
7.4.5 FibroGen Recent Development
7.5 CollPlant
7.5.1 CollPlant Company Information
7.5.2 CollPlant Business Overview
7.5.3 CollPlant Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2020-2025)
7.5.4 CollPlant Recombinant Collagen-Based Biomaterial Products Offered
7.5.5 CollPlant Recent Development
7.6 Geltor
7.6.1 Geltor Company Information
7.6.2 Geltor Business Overview
7.6.3 Geltor Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Geltor Recombinant Collagen-Based Biomaterial Products Offered
7.6.5 Geltor Recent Development
7.7 Modern Meadow
7.7.1 Modern Meadow Company Information
7.7.2 Modern Meadow Business Overview
7.7.3 Modern Meadow Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Modern Meadow Recombinant Collagen-Based Biomaterial Products Offered
7.7.5 Modern Meadow Recent Development
8 Recombinant Collagen-Based Biomaterial Manufacturing Cost Analysis
8.1 Recombinant Collagen-Based Biomaterial Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Recombinant Collagen-Based Biomaterial
8.4 Recombinant Collagen-Based Biomaterial Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Recombinant Collagen-Based Biomaterial Distributors List
9.3 Recombinant Collagen-Based Biomaterial Customers
10 Recombinant Collagen-Based Biomaterial Market Dynamics
10.1 Recombinant Collagen-Based Biomaterial Industry Trends
10.2 Recombinant Collagen-Based Biomaterial Market Drivers
10.3 Recombinant Collagen-Based Biomaterial Market Challenges
10.4 Recombinant Collagen-Based Biomaterial Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Recombinant Collagen-Based Biomaterial Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Recombinant Collagen-Based Biomaterial Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Recombinant Collagen-Based Biomaterial Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Recombinant Collagen-Based Biomaterial Sales (Tons) by Region (2020-2025)
Table 5. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Region (2020-2025)
Table 6. Global Recombinant Collagen-Based Biomaterial Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Recombinant Collagen-Based Biomaterial Revenue Share by Region (2020-2025)
Table 8. Global Recombinant Collagen-Based Biomaterial Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Recombinant Collagen-Based Biomaterial Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Recombinant Collagen-Based Biomaterial Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Recombinant Collagen-Based Biomaterial Revenue Share Forecast by Region (2026-2031)
Table 12. Global Recombinant Collagen-Based Biomaterial Sales by Type (Tons) & (2020-2025)
Table 13. Global Recombinant Collagen-Based Biomaterial Sales Share by Type (2020-2025)
Table 14. Global Recombinant Collagen-Based Biomaterial Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Recombinant Collagen-Based Biomaterial Price by Type (US$/Ton) & (2020-2025)
Table 16. Global Recombinant Collagen-Based Biomaterial Sales by Type (Tons) & (2026-2031)
Table 17. Global Recombinant Collagen-Based Biomaterial Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Recombinant Collagen-Based Biomaterial Price by Type (US$/Ton) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Recombinant Collagen-Based Biomaterial Sales by Application (Tons) & (2020-2025)
Table 21. Global Recombinant Collagen-Based Biomaterial Sales Share by Application (2020-2025)
Table 22. Global Recombinant Collagen-Based Biomaterial Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Recombinant Collagen-Based Biomaterial Price by Application (US$/Ton) & (2020-2025)
Table 24. Global Recombinant Collagen-Based Biomaterial Sales by Application (Tons) & (2026-2031)
Table 25. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Recombinant Collagen-Based Biomaterial Price by Application (US$/Ton) & (2026-2031)
Table 27. New Sources of Growth in Recombinant Collagen-Based Biomaterial Application
Table 28. Global Recombinant Collagen-Based Biomaterial Sales by Company (Tons) & (2020-2025)
Table 29. Global Recombinant Collagen-Based Biomaterial Sales Share by Company (2020-2025)
Table 30. Global Recombinant Collagen-Based Biomaterial Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Recombinant Collagen-Based Biomaterial Revenue Share by Company (2020-2025)
Table 32. Global Recombinant Collagen-Based Biomaterial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Collagen-Based Biomaterial as of 2024)
Table 33. Global Market Recombinant Collagen-Based Biomaterial Average Price by Company (US$/Ton) & (2020-2025)
Table 34. Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Product Type & Application
Table 36. Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025) & (Tons)
Table 39. North America Recombinant Collagen-Based Biomaterial Sales Market Share by Company (2020-2025)
Table 40. North America Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Recombinant Collagen-Based Biomaterial Revenue Market Share by Company (2020-2025)
Table 42. North America Recombinant Collagen-Based Biomaterial Sales by Type (2020-2025) & (Tons)
Table 43. North America Recombinant Collagen-Based Biomaterial Sales Market Share by Type (2020-2025)
Table 44. North America Recombinant Collagen-Based Biomaterial Sales by Application (2020-2025) & (Tons)
Table 45. North America Recombinant Collagen-Based Biomaterial Sales Market Share by Application (2020-2025)
Table 46. Europe Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025) & (Tons)
Table 47. Europe Recombinant Collagen-Based Biomaterial Sales Market Share by Company (2020-2025)
Table 48. Europe Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Recombinant Collagen-Based Biomaterial Revenue Market Share by Company (2020-2025)
Table 50. Europe Recombinant Collagen-Based Biomaterial Sales by Type (2020-2025) & (Tons)
Table 51. Europe Recombinant Collagen-Based Biomaterial Sales Market Share by Type (2020-2025)
Table 52. Europe Recombinant Collagen-Based Biomaterial Sales by Application (2020-2025) & (Tons)
Table 53. Europe Recombinant Collagen-Based Biomaterial Sales Market Share by Application (2020-2025)
Table 54. China Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025) & (Tons)
Table 55. China Recombinant Collagen-Based Biomaterial Sales Market Share by Company (2020-2025)
Table 56. China Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Recombinant Collagen-Based Biomaterial Revenue Market Share by Company (2020-2025)
Table 58. China Recombinant Collagen-Based Biomaterial Sales by Type (2020-2025) & (Tons)
Table 59. China Recombinant Collagen-Based Biomaterial Sales Market Share by Type (2020-2025)
Table 60. China Recombinant Collagen-Based Biomaterial Sales by Application (2020-2025) & (Tons)
Table 61. China Recombinant Collagen-Based Biomaterial Sales Market Share by Application (2020-2025)
Table 62. Japan Recombinant Collagen-Based Biomaterial Sales by Company (2020-2025) & (Tons)
Table 63. Japan Recombinant Collagen-Based Biomaterial Sales Market Share by Company (2020-2025)
Table 64. Japan Recombinant Collagen-Based Biomaterial Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Recombinant Collagen-Based Biomaterial Revenue Market Share by Company (2020-2025)
Table 66. Japan Recombinant Collagen-Based Biomaterial Sales by Type (2020-2025) & (Tons)
Table 67. Japan Recombinant Collagen-Based Biomaterial Sales Market Share by Type (2020-2025)
Table 68. Japan Recombinant Collagen-Based Biomaterial Sales by Application (2020-2025) & (Tons)
Table 69. Japan Recombinant Collagen-Based Biomaterial Sales Market Share by Application (2020-2025)
Table 70. Evonik Industries Company Information
Table 71. Evonik Industries Description and Business Overview
Table 72. Evonik Industries Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Evonik Industries Recombinant Collagen-Based Biomaterial Product
Table 74. Evonik Industries Recent Development
Table 75. Trautec Company Information
Table 76. Trautec Description and Business Overview
Table 77. Trautec Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Trautec Recombinant Collagen-Based Biomaterial Product
Table 79. Trautec Recent Development
Table 80. Genemedicine Company Information
Table 81. Genemedicine Description and Business Overview
Table 82. Genemedicine Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Genemedicine Recombinant Collagen-Based Biomaterial Product
Table 84. Genemedicine Recent Development
Table 85. FibroGen Company Information
Table 86. FibroGen Description and Business Overview
Table 87. FibroGen Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. FibroGen Recombinant Collagen-Based Biomaterial Product
Table 89. FibroGen Recent Development
Table 90. CollPlant Company Information
Table 91. CollPlant Description and Business Overview
Table 92. CollPlant Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. CollPlant Recombinant Collagen-Based Biomaterial Product
Table 94. CollPlant Recent Development
Table 95. Geltor Company Information
Table 96. Geltor Description and Business Overview
Table 97. Geltor Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Geltor Recombinant Collagen-Based Biomaterial Product
Table 99. Geltor Recent Development
Table 100. Modern Meadow Company Information
Table 101. Modern Meadow Description and Business Overview
Table 102. Modern Meadow Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Modern Meadow Recombinant Collagen-Based Biomaterial Product
Table 104. Modern Meadow Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Recombinant Collagen-Based Biomaterial Distributors List
Table 108. Recombinant Collagen-Based Biomaterial Customers List
Table 109. Recombinant Collagen-Based Biomaterial Market Trends
Table 110. Recombinant Collagen-Based Biomaterial Market Drivers
Table 111. Recombinant Collagen-Based Biomaterial Market Challenges
Table 112. Recombinant Collagen-Based Biomaterial Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Collagen-Based Biomaterial Product Picture
Figure 2. Global Recombinant Collagen-Based Biomaterial Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Type in 2024 & 2031
Figure 4. Medical Grade Recombinant Collagen Product Picture
Figure 5. Cosmetic Grade Recombinant Collagen Product Picture
Figure 6. Food Grade Recombinant Collagen Product Picture
Figure 7. Others Product Picture
Figure 8. Global Recombinant Collagen-Based Biomaterial Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Application in 2024 & 2031
Figure 10. Medical Industry Examples
Figure 11. Cosmetic Industry Examples
Figure 12. Food Industry Examples
Figure 13. Others Examples
Figure 14. Global Recombinant Collagen-Based Biomaterial Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Recombinant Collagen-Based Biomaterial Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Recombinant Collagen-Based Biomaterial Sales (Tons) Growth Rate (2020-2031)
Figure 17. Global Recombinant Collagen-Based Biomaterial Price Trends Growth Rate (2020-2031) & (US$/Ton)
Figure 18. Recombinant Collagen-Based Biomaterial Report Years Considered
Figure 19. Global Market Recombinant Collagen-Based Biomaterial Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Recombinant Collagen-Based Biomaterial Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Recombinant Collagen-Based Biomaterial Sales (Tons) Growth Rate (2020-2031)
Figure 23. Europe Recombinant Collagen-Based Biomaterial Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Recombinant Collagen-Based Biomaterial Sales (Tons) Growth Rate (2020-2031)
Figure 25. China Recombinant Collagen-Based Biomaterial Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Recombinant Collagen-Based Biomaterial Sales (Tons) Growth Rate (2020-2031)
Figure 27. Japan Recombinant Collagen-Based Biomaterial Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Recombinant Collagen-Based Biomaterial Sales (Tons) Growth Rate (2020-2031)
Figure 29. Global Recombinant Collagen-Based Biomaterial Revenue Share by Type (2020-2025)
Figure 30. Global Recombinant Collagen-Based Biomaterial Sales Share by Type (2026-2031)
Figure 31. Global Recombinant Collagen-Based Biomaterial Revenue Share by Type (2026-2031)
Figure 32. Global Recombinant Collagen-Based Biomaterial Revenue Share by Application (2020-2025)
Figure 33. Global Recombinant Collagen-Based Biomaterial Revenue Growth Rate by Application in 2020 & 2024
Figure 34. Global Recombinant Collagen-Based Biomaterial Sales Share by Application (2026-2031)
Figure 35. Global Recombinant Collagen-Based Biomaterial Revenue Share by Application (2026-2031)
Figure 36. Global Recombinant Collagen-Based Biomaterial Sales Share by Company (2024)
Figure 37. Global Recombinant Collagen-Based Biomaterial Revenue Share by Company (2024)
Figure 38. Global 5 Largest Recombinant Collagen-Based Biomaterial Players Market Share by Revenue in Recombinant Collagen-Based Biomaterial: 2020 & 2024
Figure 39. Recombinant Collagen-Based Biomaterial Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Recombinant Collagen-Based Biomaterial
Figure 41. Manufacturing Process Analysis of Recombinant Collagen-Based Biomaterial
Figure 42. Recombinant Collagen-Based Biomaterial Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives InterviewedDescription
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.
The global Recombinant Collagen-Based Biomaterial market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Recombinant Collagen-Based Biomaterial market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cosmetic Grade Recombinant Collagen in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cosmetic Industry in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Collagen-Based Biomaterial value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Related Reports
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 139
USD 4900.00
(Single User License)
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 120
USD 4350.00
(Single User License)
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 89
USD 2900.00
(Single User License)
The global market for Recombinant Collagen-Based Biomaterial was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 92
USD 2900.00
(Single User License)
The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
USD 3950.00
(Single User License)
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 136
USD 4900.00
(Single User License)
The global Recombinant Collagen-Based Biomaterial market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 130
USD 2900.00
(Single User License)
The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 100
USD 3950.00
(Single User License)
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 80
USD 4250.00
(Single User License)
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 139
USD 4900.00
(Single User License)
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 139
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 120
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 89
The global market for Recombinant Collagen-Based Biomaterial was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 92
The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 136
The global Recombinant Collagen-Based Biomaterial market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 130
The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 100
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 80
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 139
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database